Latest News
View All >>How I Eventually Gained Confidence Towards Cancer Scans
May 31st 2023
By Steve Rubin
Before every cancer scan, I used to prepare myself for the worst.
Lynparza Receives FDA Approval With Abiraterone for Treatment of Specific Patients With Prostate Cancer
May 31st 2023
By Darlene Dobkowski, MA
Lynparza plus abiraterone was approved by the FDA for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer.
FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset
May 31st 2023
By Darlene Dobkowski, MA
The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.
Hair: A Bold, Bald Statement During Cancer
May 31st 2023
By Doris Helene White
I lost my hair during cancer treatment, but now that it’s growing back, I no longer obviously look like a patient.
Conversations With Clinicians Make Way for MPN Symptom Control
May 31st 2023
By Darlene Dobkowski, MA
Some symptoms of myeloproliferative neoplasms are “pretty broad,” highlighting the importance of open communication with cancer teams to manage the symptoms and improve quality of life.
Blogs
View All >>How I Eventually Gained Confidence Towards Cancer Scans
May 31, 2023 11:00 PM
By Steve Rubin
Hair: A Bold, Bald Statement During Cancer
May 31, 2023 5:00 PM
By Doris Helene White
How I Deal With My Lynch Syndrome Diagnosis
May 30, 2023 5:00 PM
By Georgia Hurst
Cancer Treatments — and Its Long-term Effects — Are Like a Bar Fight
May 29, 2023 9:00 PM
By Brenda Denzler
Share Your Story
View All >>At 23, Cancer Never Crossed My Mind — Until My Diagnosis
May 12, 2023 7:00 PM
By Bryana Tanner
Reflection on Life 10 Years After Stem Cell Transplant
May 11, 2023 9:00 PM
By Robert Trebor
A Tearful Farewell and Armored Welcome: My Cancer Story
May 8, 2023 9:00 PM
By Denise Sirchie
Coping With Radiation Side Effects Taught Me Patience and Gratitude
May 4, 2023 1:00 PM
By Chester Freeman
